Commonwealth Equity Services, LLC Arcutis Biotherapeutics, Inc. Transaction History

Commonwealth Equity Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$7.51 - $15.0 $1,952 - $3,900	-260 Reduced 2.47%	10,259 $98,000
Q1 2023 May 11, 2023	BUY	$10.23 - $17.14 $2,659 - $4,456	260 Added 2.53%	10,519 $115,000
Q3 2021 Oct 29, 2021	SELL	$19.28 - $27.1 $964 - $1,355	-50 Reduced 0.49%	10,259 $245,000
Q2 2021 Aug 11, 2021	SELL	$24.42 - $34.75 $16,727 - $23,803	-685 Reduced 6.23%	10,309 $281,000
Q1 2021 May 04, 2021	BUY	$24.47 - $36.98 $269,023 - $406,558	10,994 New	10,994 $318,000

197

129M

738K

82K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $557M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.